9Q20 image
Deposition Date 2025-08-14
Release Date 2026-07-01
Last Version Date 2026-07-01
Entry Detail
PDB ID:
9Q20
Title:
Structure of the Measles virus Hemagglutinin ectodomain in complex with neutralizing antibody 1C08
Biological Source:
Source Organism(s):
Expression System(s):
Method Details:
Experimental Method:
Resolution:
3.25 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Protein Blast
Polymer Type:polypeptide(L)
Molecule:1C08 Fab Heavy chain
Chain IDs:A, C (auth: D)
Chain Length:249
Number of Molecules:2
Biological Source:Homo sapiens
Protein Blast
Polymer Type:polypeptide(L)
Molecule:1C08 Fab Light chain
Chain IDs:B, D (auth: E)
Chain Length:240
Number of Molecules:2
Biological Source:Homo sapiens
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin glycoprotein
Gene (Uniprot):H
Chain IDs:E (auth: C), F
Chain Length:617
Number of Molecules:2
Biological Source:Measles morbillivirus
Ligand Molecules
Primary Citation
Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins.
Cell Host Microbe 34 1067 1081.e12 (2026)
PMID: 42102820 DOI: 10.1016/j.chom.2026.04.010

Abstact

Measles virus (MeV), a highly transmissible paramyxovirus, can cause severe complications and death, particularly in infants and young children. How and where human antibodies target and neutralize MeV remain unclear. Here, we report a panel of human monoclonal antibodies (mAbs) specific for MeV hemagglutinin (H) and fusion (F) surface proteins, derived from the memory B cells of a Measles-Mumps-Rubella (MMR) vaccinee. We mapped four and five major epitope clusters on H and F, respectively, and structurally characterized representative mAbs from each epitope cluster. MAbs against both H and F offer broad, potent, picomolar-level neutralization and substantially reduce viral loads in vivo when delivered before or after viral exposure. High-resolution cryo-electron microscopy of mAb complexes with H and F reveal highly conserved contact sites of the most protective antibodies. Characterization of these fully human mAbs provides avenues for prophylactic or therapeutic intervention against re-emerging MeV.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback